Advances in antibody manufacturing using mammalian cells

Biotechnology Annual Review

Volumn 13, Issue , 2007, Pages 95-113

  Morrow Jr , K John ^a  

^a Newport Biotechnology Consultants   (United States)

Author keywords

affinity ligands; and L; bioreactor design; disposable bioreactor components; disposable devices for clarification and purification; disposable protein purification devices.; glycosylation; proprietary cell lines; protein free and serum free culture media; proteins A G; recombinant antibodies

Indexed keywords

ABCIXIMAB; ADALIMUMAB; ALEMTUZUMAB; BASILIXIMAB; BEVACIZUMAB; CETUXIMAB; DACLIZUMAB; EDRECOLOMAB; EFALIZUMAB; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; GEMTUZUMAB OZOGAMICIN; IBRITUMOMAB TIUXETAN; INFLIXIMAB; NATALIZUMAB; OKT 3; OMALIZUMAB; PALIVIZUMAB; RANIBIZUMAB; RITUXIMAB; TOSITUMOMAB I 131; TRASTUZUMAB; UNCLASSIFIED DRUG; VECTIBIX;

ACUTE GRANULOCYTIC LEUKEMIA; ALLERGIC ASTHMA; ANTIBODY PRODUCTION; BIOREACTOR; BREAST CANCER; CELL CULTURE; COLORECTAL CANCER; COMPUTER MODEL; COST; CULTURE MEDIUM; DRUG APPROVAL; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG PURIFICATION; DRUG QUALITY; GENETIC ENGINEERING; GRAFT REJECTION; HUMAN; MAMMAL CELL; MULTIPLE SCLEROSIS; NONHODGKIN LYMPHOMA; NONHUMAN; ONLINE SYSTEM; PROCESS OPTIMIZATION; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; PSORIASIS; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RHEUMATOID ARTHRITIS;

ANIMALS; ANTIBODIES; ANTIBODY-PRODUCING CELLS; CELL PHYSIOLOGY; DRUG INDUSTRY; HUMANS; MAMMALS; PROTEIN ENGINEERING;

MAMMALIA;

EID: 34548580170     PISSN: 13872656     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1387-2656(07)13005-2     Document Type: Review

References (32)

1. Freimuth P. Protein overexpression in mammalian cell lines. Genet Eng 2007; 95-100.
2. Barnes LM, Bentley CM, Moy N and Dickson AJ. Molecular analysis of successful cell line selection in transfected GS-NS0 myeloma cells. Biotechnol Bioeng 2006; Sep 25 [Epub ahead of print].
3. Kwon J., Kim B.S., Kim M.J., and Park H.W. Suspension culture of hematopoietic stem cells in stirred bioreactors. Biotechnol Lett 25 2 (2003) 179-182
4. Birch J.R., and Racher A.J. Antibody production. Adv Drug Deliv Rev 58 (2006) 671-685
5. Li J, Menzel C, Meier D, Zhang C, Dubel S and Jostock T. A comparative study of different vector designs for the mammalian expression of recombinant IgG antibodies. J Immunol Methods 2006; Nov 13 [Epub ahead of print].
6. Dinnis D.M., Stansfield S.H., Schlatter S., Smales C.M., Alete D., Birch J.R., Racher A.J., Marshall C.T., Nielsen L.K., and James D.C. Functional proteomic analysis of GS-NS0 murine myeloma cell lines with varying recombinant monoclonal antibody production rate. Biotechnol Bioeng 94 5 (2006) 830-841
7. Hale A.J., Smith C.A., Sutherland L.C., Stoneman V.E., Longthorne V., Culhane A.C., and Williams G.T. Apoptosis: molecular regulation of cell death. Eur J Biochem 236 1 (1996) 1-26
8. Lim S.F., Chuan K.H., Liu S., Loh S.O., Chung B.Y., Ong C.C., and Song Z. RNAi suppression of Bax and Bak enhances viability in fed-batch cultures of CHO cells. Metab Eng 6 (2006) 509-522
9. Girod P.A., Zahn-Zabal M., and Mermod N. Use of the chicken lysozyme 5′ matrix attachment region to generate high producer CHO cell lines. Biotechnol Bioeng 91 1 (2005) 1-11
10. Tetko I.V., Haberer G., Rudd S., Meyers B., Mewes H.W., and Mayer K.F. Spatiotemporal expression control correlates with intragenic scaffold matrix attachment regions (S/MARs) in Arabidopsis thaliana. PloS Comput Biol 2 3 (2006) e21
11. Papapetrou E.P., Ziros P.G., Micheva I.D., Zoumbos N.C., and Athanassiadou A. Gene transfer into human hematopoietic progenitor cells with an episomal vector carrying an S/MAR element. Gene Ther 13 1 (2006) 40-51
12. Schroder M., Matischak K., and Friedl P. Serum- and protein-free media formulations for the Chinese hamster ovary cell line DUKXB11. J Biotechnol 108 3 (2004) 279-292
13. Pham P.L., Perret S., Doan H.C., Cass B., St-Laurent G., Kamen A., and Durocher Y. Large-scale transient transfection of serum-free suspension-growing HEK293 EBNA1 cells: peptone additives improve cell growth and transfection efficiency. Biotechnol Bioeng 84 3 (2003) 332-342
14. Chun B.H., Park S.Y., Chung N., and Bang W.G. Enhanced production of recombinant B-domain deleted factor VIII from Chinese hamster ovary cells by propionic and butyric acids. Biotechnol Lett 25 4 (2003) 315-319
15. Chen P., and Harcum S.W. Effects of amino acid additions on ammonium stressed CHO cells. J Biotechnol 117 3 (2005) 277-286
16. Zhang J., Robinson D., and Salmon P. A novel function for selenium in biological systems: selenite as a highly effective iron carrier for Chinese hamster ovary cell growth and monoclonal antibody production. Biotech Bioeng 95 6 (2006) 1188-1197
17. Falkner, E, Appl H, Ecler, C, Losert UM, Schoffl H and Pfaller W. Serum free cell culture: the free access online database. Toxicol In Vitro 2006; 20(3): 395-400. [Epub 2005 Oct 25].
18. Spearman M., Rodriguez J., Huzel N., and Butler M. Production and glycosylation of recombinant beta-interferon in suspension and cytopore microcarrier cultures of CHO cells. Biotechnol Prog 21 1 (2005) 31-39
19. Serrato JA, Hernandez V, Estrada-Mondaca S, Palomares LA and Ramirez OT. Differences in the glycosylation profiles of a monoclonal antiobody produced by hybridomas cultured in serum supplemented, serum free or chemically defined media. Biotechnol App Biochem 2007; Jan 25 [E-Pub ahead of print].
20. Lim AC, Zhou Y, Washbrook J, Sinclair A, Fish B, Francis R, Titchner-Hooker NJ and Farid SS. Application of a decision-support tool to assess pooling strategies in perfusion culture processes under uncertainity. Biotechnol Prog 2005;21(4):1231-1242.
21. Dusting J., Sheridan J., and Hourigan K. A fluid dynamics approach to bioreactor design for cell and tissue culture. Biotechnol Bioeng 94 6 (2006) 1196-1208
22. DePalma A. Bright sky for single use bioprocess products. Genet Eng News 2006;26:1.
23. Durrschmid M., Landauer K., Simic G., Bluml G., and Doblhoff-Dier O. Scalable inoculation strategies for microcarrier-based animal cell bioprocesses. Biotechnol Bioeng 83 6 (2003) 681-686
24. Raval K., Liu C.M., and Buchs J. Large scale disposable shaking bioreactors. Bioprocess Int 4 1 (2006) 46-49
25. Schlaeppi J.M., Henke M., Mahnke M., Hartmann S., Schmitz R., Pouliquen Y., Kerins B., Weber E., Kolbinger F., and Kocher H.P. A semi-automated large scale process for the production of recombinant tagged proteins in the Baculovirus syste. Protein Expr Purif 50 2 (2006) 185-195
26. Phillips M., Cormier J., Ferrence J., Dowd C., Kiss R., Lutz H., and Carter J. Performance of a membrane absorber for trace impurity removal in biotechnology manufacturing. J Chromatogr A 1078 1-2 (2005) 74-82
27. Morenweiser R. Downstream processing of viral vectors and vaccines. Gene Ther 12 Suppl 1 (2005) S103-S110
28. Zhou J.X., and Tressel T. Basic concepts in Q membrane chromatography for large-scale antibody production. Biotechnol Prog 22 2 (2006) 341-349
29. Cossins A.J., Harrison S., Popplewell A.G., and Gore M.G. Recombinant production of a V(L) single domain antibody in E. coli and analysis of its interaction with peptostreptococcal protein L. Protein Expr Purif 51 2 (2007) 253-259
30. Platis D., Sotriffer C.A., Clonis Y., and Labrou N.E. Lock-and-key motif as a concept for designing affinity adsorbents for protein purification. J Chromatogr A 1128 1-2 (2006) 138-151
31. Georgiou G., and Segatori L. Preparative expression of secreted proteins in bacteria: status report and future prospects. Curr Opin Biotechnol 16 (2005) 538-545
32. Roque A.C., Lowe C.R., and Taipa M.A. Antibodies and genetically engineered related molecules: production and purification. Biotechnol Prog 20 3 (2004) 639-654